Wednesday, 16 October, 2024 - 08:00
Charity venture fund targets research
A not-for-profit investment vehicle aims to build a $100 million fund for WA investment.
Sue MacLeman has more than 30 years of experience as a pharmaceutical, biotechnology and medical technology executive who held senior roles in corporate, medical, commercial and business development.
She was the chief executive and board member of several ASX- and NASDAQ-listed companies in the pharmaceutical sector, and was appointed to several academic and government advisory committees.
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
1418th | ABx Group">ABx Group | -44.24% | -19.44% |
1419th | Kneomedia">Kneomedia | -44.44% | -39.75% |
1420th | Rhythm Biosciences">Rhythm Biosciences | -44.71% | -5.78% |
1421st | Mineral Resources">Mineral Resources | -44.87% | 20.03% |
1422nd | Lifestyle Communities">Lifestyle Communities | -44.88% | 2.75% |
![]() |
NEWS: Tagged in Charity venture fund targets research | 16 Oct 2024 |
![]() |
NEW ROLE: Non-Executive Director, Rhythm Biosciences | 07 Aug 2024 |
A not-for-profit investment vehicle aims to build a $100 million fund for WA investment.
Access to our data for Sue MacLeman is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Sue MacLeman is linked to 6 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.